#Cannabis #Stock News: Phyto Extractions(TM)
(CSE: $XTRX.C) (Frankfurt:D2EP) Announces Health Canada R&D License
Addendum; @adastra_labs
LANGLEY,
BC - April 22, 2021 (Investorideas.com Newswire) Phyto Extractions Inc.
(formerly, Adastra Labs Holdings Ltd.) (CSE:XTRX) (Frankfurt:D2EP)
("Phyto Extractions™" or the "Company") is pleased to
announce that it has received its R&D license addendum in Adastra Labs Inc.
that will permit some limited human testing by licensed researchers
administering or distributing cannabis to human research subjects using
cannabis obtained from a holder of a licence for processing in the final form
of cannabis.
Read this new,
featuring XTRX in full at https://www.investorideas.com/CO/XTRX/news/2021/04221RD-License-Addendum.asp
R&D
License
This
R&D license addendum will permit the Company to conduct in-house human
testing for taste of various cannabis products for assessment of taste, sights,
smell, or touch of cannabis.
“We
look forward to initiating human-studies and generating valuable consumer-based
data to support our product development pipeline and continue delivering
high-quality efficacious cannabis products to Canadians.” Stated Dr. Kyle
Boniface, PhD.”
About
Phyto Extractions™
Phyto
Extractions™ is an agricultural-scale cannabis extraction, distillation and
product manufacturer located in Langley, BC at its co-located Health Canada
Licensed Standard Processing (extraction and products, no cultivation), Sales
(extracts, topicals, and edibles), and R&D through Adastra Labs Inc. and
Analytical Testing Laboratory through Chemia Analytics Inc.
ON
BEHALF OF THE BOARD
ADASTRA
LABS HOLDINGS LTD.
Contact:
J. Scott Munro, President, CEO & Director (Chairman)
Phone:
(778) 715-5011
Email:
scott@adastralabs.ca
Forward-Looking Information:
This news release includes forward-looking
information within the meaning of Canadian securities legislation, concerning
the business of the Company. Forward-looking information is based on certain
key expectations and assumptions made by the management of the Company.
Although the Company believes that the expectations and assumptions on which
such forward-looking information is based are reasonable, undue reliance should
not be placed on the forward-looking information because the Company can give
no assurance that they will prove to be correct. Forward-looking information in
this news release includes statements with respect of the proposed name change,
proposed consolidation, the closing of the private placement and the use of
proceeds thereof. There are numerous risks and uncertainties that could cause
actual results and the Company’s plans and objectives to differ materially from
those expressed in the forward-looking information, including: (i) adverse
market conditions; (ii) risks inherent in the cannabis extraction sector in
general; (iii) inability to close the private placement for any reason, or in
the amounts expected by the Company; and (iv) other factors beyond the control
of the Company.
Actual results and future events could differ
materially from those anticipated in such information. These and all subsequent
written and oral forward-looking information are based on estimates and
opinions of management on the dates they are made and are expressly qualified
in their entirety by this notice. Except as required by law, the Company does
not intend to update these forward-looking statements.
The CSE has not reviewed or approved of any
contents of this news release.
SOURCE:
Phyto Extractions Inc.
Phyto
Extractions Inc. (CSE:XTRX) (Frankfurt:D2EP) is a featured Cannabis stock on
Investorideas.com
Disclaimer/Disclosure:
Investorideas.com
is a digital publisher of third party sourced news, articles and equity
research as well as creates original content, including video, interviews and
articles. Original content created by investorideas is protected by copyright
laws other than syndication rights. Our site does not make recommendations for
purchases or sale of stocks, services or products. Nothing on our sites should
be construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions. Disclosure: XTRX is a featured cannabis stock on
Investorideas.com and the cannabis potcast effective April 14 More disclaimer
info: https://www.investorideas.com/About/Disclaimer.asp Learn more
about publishing your news release and our other news services on the
Investorideas.com newswire https://www.investorideas.com/News-Upload/ and
tickertagstocknews.com
Global
investors must adhere to regulations of each country. Please read
Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Get more Cannabis Stock Investor Ideas - news, articles, podcasts and
stock directories
No comments:
Post a Comment